Avella Selected as Synagis Provider in Texas and Colorado
Phoenix, AZ -
(NewMediaWire) - October 1, 2013 - Avella Specialty Pharmacy has been chosen by Navitus Health Solutions LLC to provide Synagis® to its managed Medicaid members in Texas and Colorado. The prescription medication Synagis® is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in infants and children at high risk for severe lung disease from RSV.

Avella’s contract award, recently announced by Navitus, identifies Avella as a preferred specialty pharmacy partner to dispense Synagis® to Texas and Colorado Medicaid recipients.
Specialty pharmacies play a key role in providing patients with complex medical conditions access to medications and in monitoring those patients to ensure correct utilization. Working as a key component of the healthcare system, Avella collaborates with providers, payors and patients to offer unique solutions to their challenges. More information about Avella and its specialty services can be found at www.avella.com.
###
About Navitus Navitus Health Solutions, LLC is a full-service, URAC-accredited pharmacy benefit management company. Navitus provides its flexible services to government entities, self-funded employers, coalitions, labor organizations, third-party administrators, and health plans, including managed Medicaid and Medicare Part D. For more information about Navitus’ real solutions to the rising cost of health care, visit www.navitus.com or call 877-571-7500.
About Avella Specialty Pharmacy
Headquartered in Phoenix, Arizona, Avella Specialty Pharmacy is a National Accredited Specialty Pharmacy, providing individualized care and support to patients since 1996. Avella's clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The company offers a nationwide distribution service to complement its retail locations. In 2013 Avella reached 1,105th on Inc. magazine's list of the 5,000 fastest-growing private companies in the country. For more information, please visit www.avella.com.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.